Supply Chain

A bipartisan alliance of former Food and Drug Administration commissioners want the agency to become an independent federal body, according to Fortune.

The U.S. Supreme court rejected on Monday San Diego-based Sequenom's petition to review litigation that invalidated its patent on a new type of prenatal test, according to Reuters.

Medtronic will acquire HeartWare International for $1.1 billion, paying $58 per share in cash, according to The Wall Street Journal.

In an effort to improve quality control, reduce risk and significantly decrease costs, an increasing number of large hospitals and health networks are launching full-fledged self-distribution programs. Recently, we learned Michigan based Trinity Health is among the latest going self-distributed…

Hijack attacks on medical devices are on the rise, according to a study released Monday by security firm TrapX.

The Food and Drug Administration recently approved Accuray Inc.'s Radixact Treatment Delivery Platform.

The FDA has granted Breakthrough Therapy Designation to Opdivo, a drug from New York City-based drug developer Bristol-Myers Squibb that potentially treats bladder cancer.

An experimental cannabis-based epilepsy drug developed by GW Pharmaceuticals proved effective at reducing the frequency of seizures in a late-stage study, according to Reuters.

A study on Allergy Therapeutics' new hay fever treatment failed to find a recommended dose for a late-stage trial, a setback that will postpone the drug's U.S. launch by a year, according to Reuters.

As the healthcare industry sees a continued uptick in IDNs acquiring more hospitals and post-acute care providers like nursing facilities and ambulatory care sites, it’s no secret that healthcare supply chains are getting larger and more complex – leading to…